Nothing Special   »   [go: up one dir, main page]

YOSHIDA et al., 1985 - Google Patents

Purification and characterization of an antitumor principle from Streptococcus hemolyticus, Su strain

YOSHIDA et al., 1985

View PDF
Document ID
7526123350731900479
Author
YOSHIDA J
YOSHIMURA M
TAKAMURA S
KOBAYASHI S
Publication year
Publication venue
Japanese Journal of Cancer Research GANN

External Links

Snippet

An antitumor principle(SAGP) has been purified from cell-free crude extract(CE) of group A• ôNH• ôStreptococcus hemolyticus• ôNS• ô, Su strain. The antitumor activity of each fraction was evaluated by measuring the• ôNH• ôin vitro• ôNS• ô growth inhibitory effect on trans …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Ruff et al. Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Nicolson et al. Characterization of two plant lectins from Ricinus communis and their quantitative interaction with a murine lymphoma
Scala et al. Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.
Kelker et al. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin
Havell Production of tumor necrosis factor during murine listeriosis.
Inbar et al. A specific metabolic activity on the surface membrane in malignant cell-transformation
Zarkovic et al. An overview on anticancer activities of the Viscum album extract Isorel®
Molnar et al. The role of an α2-macroglobulin of rat serum in the phagocytosis of colloidal particles
Lotan et al. Aggregation and fragmentation of soybean agglutinin
EP0090892B1 (en) Process for the purification of physiologically active substance having antitumour activity
EP0132125B2 (en) A protein having antitumor activity
Williams Jr et al. Plasma protein formation in vitro by tissues from mice infected with staphylococci
KR910002520B1 (en) Cell growth inhibitory factor
Behling et al. Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time
YOSHIDA et al. Purification and characterization of an antitumor principle from Streptococcus hemolyticus, Su strain
Natori et al. Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, Meth-A
Tsukada et al. Induction of macrophage interleukin-1 production by Listeria monocytogenes hemolysin
Taylor et al. Identification of a human tumor-derived lipolysis-promoting factor
Cornelius et al. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites.
Kapp et al. Granulocyte-activating mediators (GRAM) II. Generation by human epidermal cells-relation to GM-CSF
Ternell et al. Plasma protein synthesis in experimental cancer compared to paraneoplastic conditions, including monokine administration
CA1332149C (en) Therapeutic agent for thrombocytopenia
Labib et al. Immunosuppressive factors in mouse amniotic fluid and neonate serum
Yoshida et al. Characterization of a streptococcal antitumor glycoprotein (SAGP)
Houck et al. The purification and characterization of a lymphokine chemotactic for lymphocytes-lymphotactin